World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 12 December 2020
Main ID:  NCT02255136
Date of registration: 15/02/2012
Prospective Registration: Yes
Primary sponsor: Mahesh Bhattacharyya Homoeopathic Medical College and Hospital
Public title: Efficacy Study of Homeopathic Medicines in Treatment of Allergic Rhinitis and/or Induced Bronchial Asthma SBRCTHILARBA
Scientific title: An Evidence-based Single-blind Randomized Controlled Trial Searching for the Efficacy of Homoeopathic Medicines in Reducing Serum Levels of Cytokines (IL - 10, 13) and Immunoglobulin E in Allergic Rhinitis and/or Induced Bronchial Asthma
Date of first enrolment: March 2012
Target sample size: 100
Recruitment status: Completed
URL:  https://clinicaltrials.gov/show/NCT02255136
Study type:  Interventional
Study design:  Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Single (Participant).  
Phase:  N/A
Countries of recruitment
India
Contacts
Name:     Shubhamoy Ghosh, MD(Hom)
Address: 
Telephone:
Email:
Affiliation:  Lecturer of the Department of Pathology & Microbiology
Key inclusion & exclusion criteria

Inclusion Criteria:

- Age between 5 and 65 years

- Both sexes

- Atopic: reactive to allergens with positive skin prick test (SPT) results and/or
eosinophilia

- More than 1 year history of allergic rhinitis and/or induced bronchial asthma

Exclusion Criteria:

- Nasal abnormalities causing obstruction, e.g. nasal polyp(s), deviated septum etc.

- Previous homoeopathic immunotherapy for allergic rhinitis

- Allergen avoidance in past 6 weeks

- Away from usual environment for more than 1 week during trial

- Severe asthma cases as detected clinically

- Respiratory infection

- Severe concomitant disease

- Pregnancy, breast feeding, or likelihood of pregnancy

- Oral or parenteral steroids and/or decongestant in past 6 months

- Conventional desensitization in past 3 months



Age minimum: 5 Years
Age maximum: 65 Years
Gender: All
Health Condition(s) or Problem(s) studied
Rhinitis; Allergic, With Asthma
Intervention(s)
Other: Placebo
Other: Individualized homeopathic medicines
Primary Outcome(s)
Serum Interleukin 10 and 13 level [Time Frame: 1 year]
Secondary Outcome(s)
Incidence of adverse events if any [Time Frame: 1 year]
Secondary ID(s)
793/MBHMCH/CH/Adm/01/2011
CTRI/2012/02/002419
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history